These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29472513)

  • 1. Stability of an extemporaneously compounded minoxidil oral suspension.
    Song Y; Chin ZW; Ellis D; Lwin EMP; Turner S; Williams D; Garg S
    Am J Health Syst Pharm; 2018 Mar; 75(5):309-315. PubMed ID: 29472513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of extemporaneously prepared rosuvastatin oral suspension.
    Zaid AN; Shtayah R; Qadumi A; Ghanem M; Qedan R; Daibes M; Awwad SA; Jaradat N; Kittana N
    Am J Health Syst Pharm; 2017 Oct; 74(19):1579-1583. PubMed ID: 28947528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of flecainide acetate in an extemporaneously compounded oral suspension.
    Wiest DB; Garner SS; Pagacz LR; Zeigler V
    Am J Hosp Pharm; 1992 Jun; 49(6):1467-70. PubMed ID: 1529992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K; Hutchinson DJ; Chablani L
    Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of extemporaneously prepared rifaximin oral suspensions.
    Cober MP; Johnson CE; Lee J; Currie K
    Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
    Caruthers RL; Johnson CE
    Am J Health Syst Pharm; 2007 Jul; 64(14):1513-5. PubMed ID: 17617502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL; Johnson CE; Jacobson P
    Am J Hosp Pharm; 1994 Oct; 51(19):2409-11. PubMed ID: 7847406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
    Cober MP; Johnson CE; Sudekum D; Penprase K
    Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of itraconazole in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; Walters JR
    Am J Health Syst Pharm; 1995 Jan; 52(2):189-91. PubMed ID: 12879547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of terbinafine hydrochloride in an extemporaneously prepared oral suspension at 25 and 4 degrees C.
    Abdel-Rahman SM; Nahata MC
    Am J Health Syst Pharm; 1999 Feb; 56(3):243-5. PubMed ID: 10030510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt.
    Graves RA; Mandal TK; Bostanian LA; Nguyen AT; Swopes D; Morris TC; Pramar YV
    Int J Pharm Compd; 2019; 23(6):519-527. PubMed ID: 31751949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures.
    Nguyen KQ; Hawkins MG; Taylor IT; Wiebe VJ; Tell LA
    Am J Vet Res; 2009 Jul; 70(7):908-14. PubMed ID: 19566477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of extemporaneously prepared moxifloxacin oral suspensions.
    Hutchinson DJ; Johnson CE; Klein KC
    Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of zonisamide in extemporaneously compounded oral suspensions.
    Abobo CV; Wei B; Liang D
    Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of an extemporaneously compounded terbutaline sulfate oral liquid.
    Horner RK; Johnson CE
    Am J Hosp Pharm; 1991 Feb; 48(2):293-5. PubMed ID: 2003504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical and Microbiological Stability of Compounded Clonidine Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt®.
    Pramar YV; Mandal TK; Bostanian LA; Johnson J; Graves RA
    Int J Pharm Compd; 2024; 28(4):334-343. PubMed ID: 39094046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.
    Cober MP; Johnson CE
    Am J Health Syst Pharm; 2007 Mar; 64(6):644-6. PubMed ID: 17353574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.